Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / April / A Blood Test for Early Pancreatic Cancer
Oncology Biochemistry and molecular biology Screening and monitoring Molecular Pathology

A Blood Test for Early Pancreatic Cancer

Four-marker panel increases sensitivity while maintaining specificity

04/07/2026 News 2 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Quiz
  • Poll
  • Top Institutions

Share

Top Institutions in Oncology - Pancreatic Cancer Early Detection

Leading institutions utilize advanced proteomics, mass spectrometry, and immunoassays to identify and validate novel plasma biomarkers, often combining multiple markers to enhance diagnostic accuracy. Large patient cohorts and multi-institutional collaborations support robust validation of biomarker panels.

  • #1

    University of Pennsylvania

    Philadelphia, PA

    The University of Pennsylvania is a leader in pancreatic cancer research with extensive expertise in biomarker discovery and validation, supported by strong translational research programs and access to large patient cohorts.

    Key Differentiators

    • Oncology
    • Gastroenterology
    • Molecular Diagnostics
  • #2

    Mayo Clinic

    Rochester, MN

    Mayo Clinic has a robust pancreatic cancer program with significant contributions to biomarker research and clinical validation, leveraging large, well-characterized patient cohorts and multidisciplinary expertise.

    Key Differentiators

    • Oncology
    • Gastroenterology
    • Clinical Research
  • #3

    Johns Hopkins University

    Baltimore, MD

    Johns Hopkins is renowned for pioneering pancreatic cancer research, including biomarker discovery and early detection, with strong translational research infrastructure and clinical trial programs.

    Key Differentiators

    • Oncology
    • Molecular Biology
    • Cancer Biomarkers
  • #4

    Memorial Sloan Kettering Cancer Center

    New York, NY

    MSKCC has extensive expertise in cancer biomarker research and clinical application, with a focus on integrating novel diagnostics into patient care pathways for pancreatic cancer.

    Key Differentiators

    • Oncology
    • Cancer Diagnostics
    • Translational Research

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Flexible Solutions With FlexVUE
Screening and monitoring
Flexible Solutions With FlexVUE

December 29, 2021

1 min read

Quickly customize your immune panels with Ultivue’s new innovation

What’s New in Infectious Disease? (December 2021)
Screening and monitoring
What’s New in Infectious Disease?

December 23, 2021

1 min read

The latest research and news on COVID-19 and the infectious disease landscape

A Pig In a Poke
Screening and monitoring
A Pig In a Poke

October 21, 2016

1 min read

When importing livestock for food or breeding, European countries may inadvertently open their borders to superbugs as well

Sneaky Superbugs
Screening and monitoring
Sneaky Superbugs

October 21, 2016

1 min read

Norway’s strict LA-MRSA transmission measures prevent the import of almost all live pigs – but the bacteria have found a new way in

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.